Unique ID issued by UMIN | UMIN000049138 |
---|---|
Receipt number | R000055973 |
Scientific Title | Usefulness of new liquid enteral nutrition formula in perioperative patients in the field of gastrointestinal surgery. |
Date of disclosure of the study information | 2022/11/01 |
Last modified on | 2023/01/10 17:50:56 |
Usefulness of new liquid enteral nutrition formula in perioperative patients in the field of gastrointestinal surgery.
Usefulness of new liquid enteral nutrition formula in perioperative patients.
Usefulness of new liquid enteral nutrition formula in perioperative patients in the field of gastrointestinal surgery.
Usefulness of new liquid enteral nutrition formula in perioperative patients.
Japan |
Digestive disease
Gastrointestinal surgery | Hepato-biliary-pancreatic surgery |
Malignancy
NO
For patients scheduled for gastrointestinal surgery (upper gastrointestinal tract, lower gastrointestinal tract, liver, biliary, pancreas), the new liquid enteral nutrition formula was administered as dietary therapy before and after surgery. The purpose of this study is to examine the usefulness of the new liquid enteral nutrition formula by comparing the incidence of infectious diseases, the rate of improvement in nutritional status, and other parameters.
Efficacy
Incidence of postoperative infections.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Food |
Normal hospital meal is taken from 2 days before surgery until 7 days after reaching the postoperative maintenance dose.
A new liquid enteral nutrition formula is taken from 2 days before surgery until 7 days after reaching the postoperative maintenance dose.
20 | years-old | <= |
75 | years-old | > |
Male and Female
1. Patients scheduled for surgical operation (upper gastrointestinal tract, lower gastrointestinal tract, liver, biliary, pancreas).
2. Patients who can take oral nutrition.
3. Patients aged >=20 and <75.
4. Subjects who explained this research using a written informed consent document and obtained informed consent.
1. Weight loss =>10% (compared to normal weight over the last 6 months).
2. Patients with swallowing dysfunction.
3. Patients with liver dysfunction (Child-Pugh class C).
4. Patients with respiratory dysfunction (arterial blood PaO2<70 torr).
5. Patients with renal impairment (plasma creatinine level >2 mg/dL).
6. Patients with cardiac dysfunction (New York classification>3).
7. Patients who are pregnant.
8. Patients with infectious diseases.
9. Immunocompromised patients.
10. Patients judged to require total parenteral nutrition.
11. Patients who become calorie restricted after hospitalization due to comorbidities, or who may become calorie restricted.
12. Patients judged inappropriate for participation in this research by the principal investigator or co-investigator.
200
1st name | Hiroshi |
Middle name | |
Last name | Yoshida |
Nippon Medical School Hospital
Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery
113-8603
1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan
03-3822-2131
s-shinji@nms.ac.jp
1st name | Seiichi |
Middle name | |
Last name | Shinji |
Nippon Medical School Hospital
Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery
113-8603
1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan
03-3822-2131
s-shinji@nms.ac.jp
Nippon Medical School
Nippon Medical School
Other
Central Ethics Committee of the Nippon Medical School
1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan
03-3822-2131
chuorinri.group@nms.ac.jp
NO
2022 | Year | 11 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2022 | Year | 09 | Month | 22 | Day |
2022 | Year | 09 | Month | 27 | Day |
2022 | Year | 11 | Month | 01 | Day |
2024 | Year | 10 | Month | 31 | Day |
2022 | Year | 10 | Month | 06 | Day |
2023 | Year | 01 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055973